NCT03874780View on ClinicalTrials.gov

Vibe First In Human Study for the Assessment of Safety and Initial Performance of the Vibe Delivery System in Subjects With Idiopathic Overactive Bladder

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 29, 2019

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
Overactive Bladder
Interventions
DEVICE

Vibe Delivery system

delivery of Botox (TM) to the bladder wall using an ultrasound technology with the Vibe delivery system

Trial Locations (2)

Unknown

Jablonec Nad Nisou Medical Center, Jablonec nad Nisou

Braga Medical Center, Braga

All Listed Sponsors
lead

Vensica Therapeutics Ltd.

INDUSTRY

NCT03874780 - Vibe First In Human Study for the Assessment of Safety and Initial Performance of the Vibe Delivery System in Subjects With Idiopathic Overactive Bladder | Biotech Hunter | Biotech Hunter